CORE--AUTISM SUBJECTS

$258,558P01FY2000HDNIH

Mellon Pitts Corporation (Mpc Corp), Pittsburgh PA

Investigators

Linked publications & trials

Paper 31136606 Paper 30350906 Paper 30079576 Paper 29058782 Paper 28900778 Paper 28782371 Paper 27748031 Paper 27314943 Paper 27242630 Paper 27083780 Paper 26345517 Paper 26343932 Paper 26335740 Paper 26011184 Paper 25610767 Paper 25180048 Paper 25099486 Paper 24365486 Paper 24104507 Paper 24027437 Paper 23765156 Paper 23756154 Paper 23186793 Paper 23011251 Paper 22998867 Paper 22865151 Paper 22708002 Paper 22661827 Paper 22318760 Paper 22095694 Paper 21890111 Paper 20832784 Paper 20679591 Paper 20471358 Paper 20437604 Paper 20413799 Paper 20300817 Paper 19877157 Paper 19765010 Paper 19360658 Paper 19236399 Paper 19232577 Paper 19165587 Paper 19154646 Paper 18954478 Paper 18422548 Paper 17913474 Paper 17869314 Paper 17517680 Paper 17191097 Paper 17107456 Paper 16863674 Paper 16839280 Paper 16835247 Paper 16650833 Paper 16609827 Paper 16460219 Paper 16214219 Paper 15509622 Paper 15314136 Paper 15215213 Paper 15090875

Abstract

The objectives of the Subject core are to: 1) recruit 200 rigorously diagnosed high functioning autistic subjects over the 5 year period of study, 2) recruit 200 individually matched normal controls who have a negative personal and family history of developmental and neuropsychiatric disorders, plus 10 additional normal controls of average IQ for the longitudinal study, 3) characterize autistic subjects in terms of the most likely clinical indicators of four separate genetic subgroups (family history of "lesser variant" of autism, family history of mood disorder or anxiety disorder, regression as mode of autism onset, and elevated peripheral serotonin levels), 4) administer the neuropsychologic and cognitive psychology testing from Projects I and II, and 5) provide behavioral management and support for all subjects during fMRI and laboratory eye movement procedures in Projects II and III.

View original record on NIH RePORTER →